Fingerprint
Dive into the research topics of 'Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically